Pharmacokinetic evaluation of gemcitabine hydrochloride for the treatment of cervical cancer
Author:
Publisher
Informa Healthcare
Subject
Pharmacology,Toxicology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/17425255.2011.625012
Reference54 articles.
1. Global cancer statistics
2. Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials
3. Radiosensitizers in cervical cancer. Cisplatin and beyond
4. Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix
5. Antiviral activity of 5-substituted pyrimidine nucleoside analogues
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. lncRNA DLG1‐AS1 promotes cervical cancer cell gemcitabine resistance by regulating miR ‐16‐5p/ HDGF;Journal of Obstetrics and Gynaecology Research;2022-04-07
2. Cyclic RGDfK Peptide Functionalized Polymeric Nanocarriers for Targeting Gemcitabine to Ovarian Cancer Cells;Molecular Pharmaceutics;2016-03-28
3. To determine the half-life for gemcitabine hydrochloride using microcalorimetry;Journal of Thermal Analysis and Calorimetry;2013-09-08
4. Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing® for efficient antitumor activity;International Journal of Pharmaceutics;2013-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3